In Reply — Immune Checkpoint Inhibitor–Induced Type 1 Diabetes: An Underestimated Risk
Mayo Clinic Proceedings - Netherlands
doi 10.1016/j.mayocp.2019.12.010
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2020
Authors
Publisher
Elsevier BV